32
Views
9
CrossRef citations to date
0
Altmetric
Review

Intratumoural administration of dendritic cells: hostile environment and help by gene therapy

, , , , , , , , , & show all
Pages 7-22 | Published online: 20 Apr 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michael R Shurin, Melissa Gregory, John C Morris & Anatoli M Malyguine. (2010) Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?. Expert Opinion on Biological Therapy 10:11, pages 1539-1553.
Read now

Articles from other publishers (8)

Ignacio Melero, Eduardo Castanon, Maite Alvarez, Stephane Champiat & Aurelien Marabelle. (2021) Intratumoural administration and tumour tissue targeting of cancer immunotherapies. Nature Reviews Clinical Oncology 18:9, pages 558-576.
Crossref
A.R. Sánchez-Paulete, A. Teijeira, F.J. Cueto, S. Garasa, J.L. Pérez-Gracia, A. Sánchez-Arráez, D. Sancho & I. Melero. (2017) Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy. Annals of Oncology 28, pages xii44-xii55.
Crossref
Jacob Osterbur, Leslee Sprague, Maria Muccioli, Michelle Pate, Kristen Mansfield, John McGinty, Yihan Li, Yandi Li, Venktesh Shirure, Maria Cecilia Courreges & Fabian Benencia. (2013) Adhesion to substrates induces dendritic cell endothelization and decreases immunological response. Immunobiology 218:1, pages 64-75.
Crossref
Carlos Alfaro, Natalia Suárez, Ivan Martínez-Forero, Asís Palazón, Ana Rouzaut, Sarai Solano, Esperanza Feijoo, Alfonso Gúrpide, Elixabet Bolaños, Lorena Erro, Juan Dubrot, Sandra Hervás-Stubbs, Alvaro Gonzalez, Jose Luis Perez-Gracia & Ignacio Melero. (2011) Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation. PLoS ONE 6:3, pages e17922.
Crossref
Oihana Murillo, Juan Dubrot, Asís Palazón, Ainhoa Arina, Arantza Azpilikueta, Carlos Alfaro, Sarai Solano, María C. Ochoa, Carmen Berasain, Izaskun Gabari, José. L. Pérez‐Gracia, Pedro Berraondo, Sandra Hervás‐Stubbs & Ignacio Melero. (2009) In vivo depletion of DC impairs the anti‐tumor effect of agonistic anti‐CD137 mAb . European Journal of Immunology 39:9, pages 2424-2436.
Crossref
Alessandro Zerbini, Massimo Pilli, Francesco Fagnoni, Guido Pelosi, Maria Grazia Pizzi, Simona Schivazappa, Diletta Laccabue, Cristina Cavallo, Claudia Schianchi, Carlo Ferrari & Gabriele Missale. (2008) Increased Immunostimulatory Activity Conferred to Antigen-presenting Cells by Exposure to Antigen Extract From Hepatocellular Carcinoma After Radiofrequency Thermal Ablation. Journal of Immunotherapy 31:3, pages 271-282.
Crossref
Ainhoa Arina, Oihana Murillo, Sandra Hervás‐Stubbs, Arantza Azpilikueta, Juan Dubrot, Iñigo Tirapu, Eduardo Huarte, Carlos Alfaro, Jose L. Pérez‐Gracia, Gloria González‐Aseguinolaza, Pablo Sarobe, Juan J. Lasarte, Amanda Jamieson, Jesús Prieto, David H. Raulet & Ignacio Melero. (2007) The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ. International Journal of Cancer 121:6, pages 1282-1295.
Crossref
Ignacio Melero, Ainhoa Arina, Oihana Murillo, Juan Dubrot, Carlos Alfaro, Jose L. Pérez-Gracia, Maurizio Bendandi & Sandra Hervás-Stubbs. (2006) Immunogenic Cell Death and Cross-Priming Are Reaching the Clinical Immunotherapy Arena. Clinical Cancer Research 12:8, pages 2385-2389.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.